
Richard Taylor
Chief Financial Officer
Richard Taylor has over 35 years of experience in supporting biotechnology companies from a financial perspective. He spent 16 years with Syntex/Roche including Director of Finance for the Development Research division with an annual budget over $200M. He has spent the last 20 years as the CFO/senior finance officer with various start-up biotech and medical device companies. He has B.S. from the University of California-Berkeley in Biology, a M.S. in Biology from Stanford University and a MBA from the University of Chicago.
Management Team
Shaun R. Bagai
Ramtin Agah, MD
Kamran Najmabadi
Paul Manners
Board of Directors
Shaun R. Bagai
Ramtin Agah, MD
Laurence J. Marton, MD
Una S. Ryan, PhD, OBE
Advisory Board
Jacob Cynamon, MD
Mike Pishvaian, MD, PhD
Peter Muscarella, MD
Associate Program Director, General Surgery Residency Training Program Montefiore Medical Center, Bronx, NY
Karyn A. Goodman, MD, MS
Associate Director of Clinical Research, The Tisch Cancer Institute at Mount Sinai
Daniel D. Von Hoff, MD, FACP
Chief Scientific Officer for US Oncology and for HonorHealth’s Clinical Research Institute
Clinical Professor of Medicine, University of Arizona, Tucson, AZ